Log In
Print
BCIQ
Print
Print this Print this
 

Avastin, bevacizumab (RG435)

Also known as: Anti-VEGF antibody (R435)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionHumanized mAb against VEGF
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today